Acetaminophen Oral Suspension Recalled for Contaminated Excipient
Perrigo is recalling Acetaminophen Oral Suspension Grape Flavor (160 mg/5 mL, 16 fl oz bottles) nationwide because the product was manufactured with a contaminated excipient that was recalled by the excipient supplier.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall. The source text identifies a CGMP deviation involving a contaminated excipient but does not report any illnesses, injuries, or deaths. This is a manufacturing quality control issue with a precautionary basis.
Plain-English summary
Perrigo Company PLC is recalling Acetaminophen Oral Suspension Grape Flavor, 160 mg per 5 mL, 16 fl oz (473 mL) bottles distributed nationwide in the United States. The recall was initiated because the product was manufactured with a contaminated excipient that had been recalled from the excipient supplier, representing a deviation from Current Good Manufacturing Practice (CGMP) standards.
Affected bottles have NDC 50941-009-43, Batch 1AK1031, with an expiration date of 12/31/2022. A total of 14,868 bottles were distributed.
Consumers who have this product should discontinue use. For questions or to report adverse events, consumers should contact Perrigo or consult their healthcare provider.
The recalled product
- Product
- Acetaminophen Oral Suspension Grape Flavor, 160 mg per 5 mL, 16 fl oz (473 mL) per bottle, Distributed by Perrigo, Allegan, MI 49010. NDC: 50941-009-43
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Oral Suspension
- Affected units
- 14,868
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1AK1031
- Exp 12/31/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 51 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 51 products in this recall →Related recalls
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · contaminated excipient
See all →- ModerateEquate Children's Pain and Fever recalled due to contaminated excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Infant Pain and Fever Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
Similar recalls
- ModerateAcetaminophen Oral Suspension Recalled Due to Contaminated Raw Ingredient
FDA (Drugs) · 2021-11-17
- ModerateL. Perrigo Recalls Infants' Acetaminophen Due to Unmarked Dosing Syringes
FDA (Drugs) · 2013-11-27
- HighAcetaminophen Oral Solution 160 mg Recalled for Manufacturing Control Deviations
FDA (Drugs) · 2022-09-14
- ModerateBio-Pharm Recalls Acetaminophen Oral Suspension Due to Assay Failure
FDA (Drugs) · 2014-10-29
- SevereQualitest Recalls Children's Acetaminophen Suspension for Assay Failure
FDA (Drugs) · 2014-10-29
- ModerateL. Perrigo Recalls Infants' Acetaminophen Suspension Due to Dosing Syringe Markings
FDA (Drugs) · 2013-11-27